[go: up one dir, main page]

Rizza et al., 2021 - Google Patents

IL-6 levels influence 3-month all-cause mortality in frail hospitalized older patients

Rizza et al., 2021

View HTML
Document ID
3336136733646817804
Author
Rizza S
Morabito P
De Meo L
Farcomeni A
Testorio G
Cardellini M
Ballanti M
Davato F
Pecchioli C
Di Cola G
Mavilio M
Federici M
Publication year
Publication venue
Aging and disease

External Links

Snippet

The multidimensional prognostic index (MPI) is a sensitive and specific prognosis estimation tool that accurately predicts all-cause mortality in frail older patients. It has been validated to assess the risk of 1-month to 2-year mortality in frail older patients during hospitalization and …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345Medical expert systems, neural networks or other automated diagnosis
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3431Calculating a health index for the patient, e.g. for risk assessment
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Chaulin Cardiac troponins: contemporary biological data and new methods of determination
Yaffe et al. Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study
Tavil et al. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients
Huang et al. The relationship between mean telomere length and blood pressure: results from the National Health and Nutrition Examination Surveys
Tang et al. Performance of high-sensitivity cardiac troponin assays to reflect comorbidity burden and improve mortality risk stratification in older adults with diabetes
Lisiak et al. Frailty and quality of life in elderly patients with acute coronary syndrome
Heikkilä et al. Associations of coeliac disease with coronary heart disease and cerebrovascular disease: A systematic review and meta-analysis
She et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in patients with overweight/obesity
Vernekar et al. Comparison of mean platelet volume in type 2 diabetics on insulin therapy and on oral hypoglycaemic agents
Martin et al. Predicting ICU readmission among surgical ICU patients: Development and validation of a clinical nomogram
Schutte et al. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression
Rizza et al. IL-6 levels influence 3-month all-cause mortality in frail hospitalized older patients
Song et al. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Gu et al. The association between red blood cell distribution width and the severity of diabetic chronic kidney disease
Vaucher et al. Genetic variants associated with type 2 diabetes and adiposity and risk of intracranial and abdominal aortic aneurysms
Kavsak et al. Identifying very-low-risk patients for future myocardial infarction or death
Wang et al. High level of serum uric acid induced monocyte inflammation is related to coronary calcium deposition in the middle-aged and elder population of China: a five-year prospective cohort study
Cayuela et al. Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?
Mumma et al. Diagnostic reclassification by a high-sensitivity cardiac troponin assay
He et al. Sex-specific differences in the effect of lymphocyte-to-C-reactive protein ratio on subclinical myocardial injury in the general population free from cardiovascular disease
Huang et al. U-shaped association of uric acid to HDL cholesterol ratio (UHR) with ALL-cause and cardiovascular mortality in diabetic patients: NHANES 1999–2018
Cui et al. Association between Age and the 28-Day all-cause Mortality in Tuberculosis complicated by Sepsis in ICU patients: a retrospective cohort study
Yang et al. The impact of nutritional and inflammatory status on mortality in stroke patients: Results from NHANES 2005-2018
Kavsak et al. High-sensitivity cardiac troponin I vs a clinical chemistry score for predicting all-cause mortality in an emergency department population
Di Chiara et al. Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities